Global BCG Tuberculosis (TB) Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global BCG Tuberculosis (TB) Vaccine market size was valued at USD 31 million in 2023 and is forecast to a readjusted size of USD 37 million by 2030 with a CAGR of 2.8% during review period.
BCG Tuberculosis (TB) Vaccine is a vaccine primarily used against tuberculosis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the BCG Tuberculosis (TB) Vaccine industry chain, the market status of Hospital (Immune BCG, Therapy BCG), Clinic (Immune BCG, Therapy BCG), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of BCG Tuberculosis (TB) Vaccine.
Regionally, the report analyzes the BCG Tuberculosis (TB) Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global BCG Tuberculosis (TB) Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the BCG Tuberculosis (TB) Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the BCG Tuberculosis (TB) Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Immune BCG, Therapy BCG).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the BCG Tuberculosis (TB) Vaccine market.
Regional Analysis: The report involves examining the BCG Tuberculosis (TB) Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the BCG Tuberculosis (TB) Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to BCG Tuberculosis (TB) Vaccine:
Company Analysis: Report covers individual BCG Tuberculosis (TB) Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards BCG Tuberculosis (TB) Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to BCG Tuberculosis (TB) Vaccine. It assesses the current state, advancements, and potential future developments in BCG Tuberculosis (TB) Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the BCG Tuberculosis (TB) Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
BCG Tuberculosis (TB) Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe BCG Tuberculosis (TB) Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of BCG Tuberculosis (TB) Vaccine, with price, sales, revenue and global market share of BCG Tuberculosis (TB) Vaccine from 2019 to 2024.
Chapter 3, the BCG Tuberculosis (TB) Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the BCG Tuberculosis (TB) Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and BCG Tuberculosis (TB) Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of BCG Tuberculosis (TB) Vaccine.
Chapter 14 and 15, to describe BCG Tuberculosis (TB) Vaccine sales channel, distributors, customers, research findings and conclusion.
BCG Tuberculosis (TB) Vaccine is a vaccine primarily used against tuberculosis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the BCG Tuberculosis (TB) Vaccine industry chain, the market status of Hospital (Immune BCG, Therapy BCG), Clinic (Immune BCG, Therapy BCG), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of BCG Tuberculosis (TB) Vaccine.
Regionally, the report analyzes the BCG Tuberculosis (TB) Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global BCG Tuberculosis (TB) Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the BCG Tuberculosis (TB) Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the BCG Tuberculosis (TB) Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Immune BCG, Therapy BCG).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the BCG Tuberculosis (TB) Vaccine market.
Regional Analysis: The report involves examining the BCG Tuberculosis (TB) Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the BCG Tuberculosis (TB) Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to BCG Tuberculosis (TB) Vaccine:
Company Analysis: Report covers individual BCG Tuberculosis (TB) Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards BCG Tuberculosis (TB) Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to BCG Tuberculosis (TB) Vaccine. It assesses the current state, advancements, and potential future developments in BCG Tuberculosis (TB) Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the BCG Tuberculosis (TB) Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
BCG Tuberculosis (TB) Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Immune BCG
- Therapy BCG
- Hospital
- Clinic
- Merck
- Sanofi Pasteur
- Japan BCG Lab
- China National Biotec
- Serum Institute of India
- Intervax
- GSBPL
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe BCG Tuberculosis (TB) Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of BCG Tuberculosis (TB) Vaccine, with price, sales, revenue and global market share of BCG Tuberculosis (TB) Vaccine from 2019 to 2024.
Chapter 3, the BCG Tuberculosis (TB) Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the BCG Tuberculosis (TB) Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and BCG Tuberculosis (TB) Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of BCG Tuberculosis (TB) Vaccine.
Chapter 14 and 15, to describe BCG Tuberculosis (TB) Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of BCG Tuberculosis (TB) Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global BCG Tuberculosis (TB) Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Immune BCG
1.3.3 Therapy BCG
1.4 Market Analysis by Application
1.4.1 Overview: Global BCG Tuberculosis (TB) Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.5 Global BCG Tuberculosis (TB) Vaccine Market Size & Forecast
1.5.1 Global BCG Tuberculosis (TB) Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global BCG Tuberculosis (TB) Vaccine Sales Quantity (2019-2030)
1.5.3 Global BCG Tuberculosis (TB) Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck BCG Tuberculosis (TB) Vaccine Product and Services
2.1.4 Merck BCG Tuberculosis (TB) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck Recent Developments/Updates
2.2 Sanofi Pasteur
2.2.1 Sanofi Pasteur Details
2.2.2 Sanofi Pasteur Major Business
2.2.3 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Product and Services
2.2.4 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Pasteur Recent Developments/Updates
2.3 Japan BCG Lab
2.3.1 Japan BCG Lab Details
2.3.2 Japan BCG Lab Major Business
2.3.3 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Product and Services
2.3.4 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Japan BCG Lab Recent Developments/Updates
2.4 China National Biotec
2.4.1 China National Biotec Details
2.4.2 China National Biotec Major Business
2.4.3 China National Biotec BCG Tuberculosis (TB) Vaccine Product and Services
2.4.4 China National Biotec BCG Tuberculosis (TB) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 China National Biotec Recent Developments/Updates
2.5 Serum Institute of India
2.5.1 Serum Institute of India Details
2.5.2 Serum Institute of India Major Business
2.5.3 Serum Institute of India BCG Tuberculosis (TB) Vaccine Product and Services
2.5.4 Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Serum Institute of India Recent Developments/Updates
2.6 Intervax
2.6.1 Intervax Details
2.6.2 Intervax Major Business
2.6.3 Intervax BCG Tuberculosis (TB) Vaccine Product and Services
2.6.4 Intervax BCG Tuberculosis (TB) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Intervax Recent Developments/Updates
2.7 GSBPL
2.7.1 GSBPL Details
2.7.2 GSBPL Major Business
2.7.3 GSBPL BCG Tuberculosis (TB) Vaccine Product and Services
2.7.4 GSBPL BCG Tuberculosis (TB) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 GSBPL Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BCG TUBERCULOSIS (TB) VACCINE BY MANUFACTURER
3.1 Global BCG Tuberculosis (TB) Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global BCG Tuberculosis (TB) Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of BCG Tuberculosis (TB) Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 BCG Tuberculosis (TB) Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 BCG Tuberculosis (TB) Vaccine Manufacturer Market Share in 2023
3.5 BCG Tuberculosis (TB) Vaccine Market: Overall Company Footprint Analysis
3.5.1 BCG Tuberculosis (TB) Vaccine Market: Region Footprint
3.5.2 BCG Tuberculosis (TB) Vaccine Market: Company Product Type Footprint
3.5.3 BCG Tuberculosis (TB) Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global BCG Tuberculosis (TB) Vaccine Market Size by Region
4.1.1 Global BCG Tuberculosis (TB) Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global BCG Tuberculosis (TB) Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global BCG Tuberculosis (TB) Vaccine Average Price by Region (2019-2030)
4.2 North America BCG Tuberculosis (TB) Vaccine Consumption Value (2019-2030)
4.3 Europe BCG Tuberculosis (TB) Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific BCG Tuberculosis (TB) Vaccine Consumption Value (2019-2030)
4.5 South America BCG Tuberculosis (TB) Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa BCG Tuberculosis (TB) Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2030)
5.2 Global BCG Tuberculosis (TB) Vaccine Consumption Value by Type (2019-2030)
5.3 Global BCG Tuberculosis (TB) Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2030)
6.2 Global BCG Tuberculosis (TB) Vaccine Consumption Value by Application (2019-2030)
6.3 Global BCG Tuberculosis (TB) Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2030)
7.2 North America BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2030)
7.3 North America BCG Tuberculosis (TB) Vaccine Market Size by Country
7.3.1 North America BCG Tuberculosis (TB) Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America BCG Tuberculosis (TB) Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe BCG Tuberculosis (TB) Vaccine Market Size by Country
8.3.1 Europe BCG Tuberculosis (TB) Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe BCG Tuberculosis (TB) Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific BCG Tuberculosis (TB) Vaccine Market Size by Region
9.3.1 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific BCG Tuberculosis (TB) Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2030)
10.2 South America BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2030)
10.3 South America BCG Tuberculosis (TB) Vaccine Market Size by Country
10.3.1 South America BCG Tuberculosis (TB) Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America BCG Tuberculosis (TB) Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa BCG Tuberculosis (TB) Vaccine Market Size by Country
11.3.1 Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa BCG Tuberculosis (TB) Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 BCG Tuberculosis (TB) Vaccine Market Drivers
12.2 BCG Tuberculosis (TB) Vaccine Market Restraints
12.3 BCG Tuberculosis (TB) Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of BCG Tuberculosis (TB) Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of BCG Tuberculosis (TB) Vaccine
13.3 BCG Tuberculosis (TB) Vaccine Production Process
13.4 BCG Tuberculosis (TB) Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 BCG Tuberculosis (TB) Vaccine Typical Distributors
14.3 BCG Tuberculosis (TB) Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of BCG Tuberculosis (TB) Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global BCG Tuberculosis (TB) Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Immune BCG
1.3.3 Therapy BCG
1.4 Market Analysis by Application
1.4.1 Overview: Global BCG Tuberculosis (TB) Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.5 Global BCG Tuberculosis (TB) Vaccine Market Size & Forecast
1.5.1 Global BCG Tuberculosis (TB) Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global BCG Tuberculosis (TB) Vaccine Sales Quantity (2019-2030)
1.5.3 Global BCG Tuberculosis (TB) Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck BCG Tuberculosis (TB) Vaccine Product and Services
2.1.4 Merck BCG Tuberculosis (TB) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck Recent Developments/Updates
2.2 Sanofi Pasteur
2.2.1 Sanofi Pasteur Details
2.2.2 Sanofi Pasteur Major Business
2.2.3 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Product and Services
2.2.4 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Pasteur Recent Developments/Updates
2.3 Japan BCG Lab
2.3.1 Japan BCG Lab Details
2.3.2 Japan BCG Lab Major Business
2.3.3 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Product and Services
2.3.4 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Japan BCG Lab Recent Developments/Updates
2.4 China National Biotec
2.4.1 China National Biotec Details
2.4.2 China National Biotec Major Business
2.4.3 China National Biotec BCG Tuberculosis (TB) Vaccine Product and Services
2.4.4 China National Biotec BCG Tuberculosis (TB) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 China National Biotec Recent Developments/Updates
2.5 Serum Institute of India
2.5.1 Serum Institute of India Details
2.5.2 Serum Institute of India Major Business
2.5.3 Serum Institute of India BCG Tuberculosis (TB) Vaccine Product and Services
2.5.4 Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Serum Institute of India Recent Developments/Updates
2.6 Intervax
2.6.1 Intervax Details
2.6.2 Intervax Major Business
2.6.3 Intervax BCG Tuberculosis (TB) Vaccine Product and Services
2.6.4 Intervax BCG Tuberculosis (TB) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Intervax Recent Developments/Updates
2.7 GSBPL
2.7.1 GSBPL Details
2.7.2 GSBPL Major Business
2.7.3 GSBPL BCG Tuberculosis (TB) Vaccine Product and Services
2.7.4 GSBPL BCG Tuberculosis (TB) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 GSBPL Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BCG TUBERCULOSIS (TB) VACCINE BY MANUFACTURER
3.1 Global BCG Tuberculosis (TB) Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global BCG Tuberculosis (TB) Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of BCG Tuberculosis (TB) Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 BCG Tuberculosis (TB) Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 BCG Tuberculosis (TB) Vaccine Manufacturer Market Share in 2023
3.5 BCG Tuberculosis (TB) Vaccine Market: Overall Company Footprint Analysis
3.5.1 BCG Tuberculosis (TB) Vaccine Market: Region Footprint
3.5.2 BCG Tuberculosis (TB) Vaccine Market: Company Product Type Footprint
3.5.3 BCG Tuberculosis (TB) Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global BCG Tuberculosis (TB) Vaccine Market Size by Region
4.1.1 Global BCG Tuberculosis (TB) Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global BCG Tuberculosis (TB) Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global BCG Tuberculosis (TB) Vaccine Average Price by Region (2019-2030)
4.2 North America BCG Tuberculosis (TB) Vaccine Consumption Value (2019-2030)
4.3 Europe BCG Tuberculosis (TB) Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific BCG Tuberculosis (TB) Vaccine Consumption Value (2019-2030)
4.5 South America BCG Tuberculosis (TB) Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa BCG Tuberculosis (TB) Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2030)
5.2 Global BCG Tuberculosis (TB) Vaccine Consumption Value by Type (2019-2030)
5.3 Global BCG Tuberculosis (TB) Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2030)
6.2 Global BCG Tuberculosis (TB) Vaccine Consumption Value by Application (2019-2030)
6.3 Global BCG Tuberculosis (TB) Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2030)
7.2 North America BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2030)
7.3 North America BCG Tuberculosis (TB) Vaccine Market Size by Country
7.3.1 North America BCG Tuberculosis (TB) Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America BCG Tuberculosis (TB) Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe BCG Tuberculosis (TB) Vaccine Market Size by Country
8.3.1 Europe BCG Tuberculosis (TB) Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe BCG Tuberculosis (TB) Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific BCG Tuberculosis (TB) Vaccine Market Size by Region
9.3.1 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific BCG Tuberculosis (TB) Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2030)
10.2 South America BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2030)
10.3 South America BCG Tuberculosis (TB) Vaccine Market Size by Country
10.3.1 South America BCG Tuberculosis (TB) Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America BCG Tuberculosis (TB) Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa BCG Tuberculosis (TB) Vaccine Market Size by Country
11.3.1 Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa BCG Tuberculosis (TB) Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 BCG Tuberculosis (TB) Vaccine Market Drivers
12.2 BCG Tuberculosis (TB) Vaccine Market Restraints
12.3 BCG Tuberculosis (TB) Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of BCG Tuberculosis (TB) Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of BCG Tuberculosis (TB) Vaccine
13.3 BCG Tuberculosis (TB) Vaccine Production Process
13.4 BCG Tuberculosis (TB) Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 BCG Tuberculosis (TB) Vaccine Typical Distributors
14.3 BCG Tuberculosis (TB) Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global BCG Tuberculosis (TB) Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global BCG Tuberculosis (TB) Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck BCG Tuberculosis (TB) Vaccine Product and Services
Table 6. Merck BCG Tuberculosis (TB) Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck Recent Developments/Updates
Table 8. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Pasteur Major Business
Table 10. Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Product and Services
Table 11. Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi Pasteur Recent Developments/Updates
Table 13. Japan BCG Lab Basic Information, Manufacturing Base and Competitors
Table 14. Japan BCG Lab Major Business
Table 15. Japan BCG Lab BCG Tuberculosis (TB) Vaccine Product and Services
Table 16. Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Japan BCG Lab Recent Developments/Updates
Table 18. China National Biotec Basic Information, Manufacturing Base and Competitors
Table 19. China National Biotec Major Business
Table 20. China National Biotec BCG Tuberculosis (TB) Vaccine Product and Services
Table 21. China National Biotec BCG Tuberculosis (TB) Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. China National Biotec Recent Developments/Updates
Table 23. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 24. Serum Institute of India Major Business
Table 25. Serum Institute of India BCG Tuberculosis (TB) Vaccine Product and Services
Table 26. Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Serum Institute of India Recent Developments/Updates
Table 28. Intervax Basic Information, Manufacturing Base and Competitors
Table 29. Intervax Major Business
Table 30. Intervax BCG Tuberculosis (TB) Vaccine Product and Services
Table 31. Intervax BCG Tuberculosis (TB) Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Intervax Recent Developments/Updates
Table 33. GSBPL Basic Information, Manufacturing Base and Competitors
Table 34. GSBPL Major Business
Table 35. GSBPL BCG Tuberculosis (TB) Vaccine Product and Services
Table 36. GSBPL BCG Tuberculosis (TB) Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. GSBPL Recent Developments/Updates
Table 38. Global BCG Tuberculosis (TB) Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 39. Global BCG Tuberculosis (TB) Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 40. Global BCG Tuberculosis (TB) Vaccine Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 41. Market Position of Manufacturers in BCG Tuberculosis (TB) Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 42. Head Office and BCG Tuberculosis (TB) Vaccine Production Site of Key Manufacturer
Table 43. BCG Tuberculosis (TB) Vaccine Market: Company Product Type Footprint
Table 44. BCG Tuberculosis (TB) Vaccine Market: Company Product Application Footprint
Table 45. BCG Tuberculosis (TB) Vaccine New Market Entrants and Barriers to Market Entry
Table 46. BCG Tuberculosis (TB) Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global BCG Tuberculosis (TB) Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 48. Global BCG Tuberculosis (TB) Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 49. Global BCG Tuberculosis (TB) Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 50. Global BCG Tuberculosis (TB) Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 51. Global BCG Tuberculosis (TB) Vaccine Average Price by Region (2019-2024) & (USD/Unit)
Table 52. Global BCG Tuberculosis (TB) Vaccine Average Price by Region (2025-2030) & (USD/Unit)
Table 53. Global BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 54. Global BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 55. Global BCG Tuberculosis (TB) Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 56. Global BCG Tuberculosis (TB) Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 57. Global BCG Tuberculosis (TB) Vaccine Average Price by Type (2019-2024) & (USD/Unit)
Table 58. Global BCG Tuberculosis (TB) Vaccine Average Price by Type (2025-2030) & (USD/Unit)
Table 59. Global BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 60. Global BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 61. Global BCG Tuberculosis (TB) Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 62. Global BCG Tuberculosis (TB) Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 63. Global BCG Tuberculosis (TB) Vaccine Average Price by Application (2019-2024) & (USD/Unit)
Table 64. Global BCG Tuberculosis (TB) Vaccine Average Price by Application (2025-2030) & (USD/Unit)
Table 65. North America BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 66. North America BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 67. North America BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 68. North America BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 69. North America BCG Tuberculosis (TB) Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 70. North America BCG Tuberculosis (TB) Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 71. North America BCG Tuberculosis (TB) Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 72. North America BCG Tuberculosis (TB) Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 73. Europe BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 74. Europe BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 75. Europe BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 76. Europe BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 77. Europe BCG Tuberculosis (TB) Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 78. Europe BCG Tuberculosis (TB) Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 79. Europe BCG Tuberculosis (TB) Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe BCG Tuberculosis (TB) Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 82. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 83. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 84. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 85. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 86. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 87. Asia-Pacific BCG Tuberculosis (TB) Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 88. Asia-Pacific BCG Tuberculosis (TB) Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 89. South America BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 90. South America BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 91. South America BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 92. South America BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 93. South America BCG Tuberculosis (TB) Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 94. South America BCG Tuberculosis (TB) Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 95. South America BCG Tuberculosis (TB) Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 96. South America BCG Tuberculosis (TB) Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 97. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 98. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 99. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 100. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 101. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 102. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 103. Middle East & Africa BCG Tuberculosis (TB) Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 104. Middle East & Africa BCG Tuberculosis (TB) Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 105. BCG Tuberculosis (TB) Vaccine Raw Material
Table 106. Key Manufacturers of BCG Tuberculosis (TB) Vaccine Raw Materials
Table 107. BCG Tuberculosis (TB) Vaccine Typical Distributors
Table 108. BCG Tuberculosis (TB) Vaccine Typical Customers
Table 1. Global BCG Tuberculosis (TB) Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global BCG Tuberculosis (TB) Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck BCG Tuberculosis (TB) Vaccine Product and Services
Table 6. Merck BCG Tuberculosis (TB) Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck Recent Developments/Updates
Table 8. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Pasteur Major Business
Table 10. Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Product and Services
Table 11. Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi Pasteur Recent Developments/Updates
Table 13. Japan BCG Lab Basic Information, Manufacturing Base and Competitors
Table 14. Japan BCG Lab Major Business
Table 15. Japan BCG Lab BCG Tuberculosis (TB) Vaccine Product and Services
Table 16. Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Japan BCG Lab Recent Developments/Updates
Table 18. China National Biotec Basic Information, Manufacturing Base and Competitors
Table 19. China National Biotec Major Business
Table 20. China National Biotec BCG Tuberculosis (TB) Vaccine Product and Services
Table 21. China National Biotec BCG Tuberculosis (TB) Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. China National Biotec Recent Developments/Updates
Table 23. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 24. Serum Institute of India Major Business
Table 25. Serum Institute of India BCG Tuberculosis (TB) Vaccine Product and Services
Table 26. Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Serum Institute of India Recent Developments/Updates
Table 28. Intervax Basic Information, Manufacturing Base and Competitors
Table 29. Intervax Major Business
Table 30. Intervax BCG Tuberculosis (TB) Vaccine Product and Services
Table 31. Intervax BCG Tuberculosis (TB) Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Intervax Recent Developments/Updates
Table 33. GSBPL Basic Information, Manufacturing Base and Competitors
Table 34. GSBPL Major Business
Table 35. GSBPL BCG Tuberculosis (TB) Vaccine Product and Services
Table 36. GSBPL BCG Tuberculosis (TB) Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. GSBPL Recent Developments/Updates
Table 38. Global BCG Tuberculosis (TB) Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 39. Global BCG Tuberculosis (TB) Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 40. Global BCG Tuberculosis (TB) Vaccine Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 41. Market Position of Manufacturers in BCG Tuberculosis (TB) Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 42. Head Office and BCG Tuberculosis (TB) Vaccine Production Site of Key Manufacturer
Table 43. BCG Tuberculosis (TB) Vaccine Market: Company Product Type Footprint
Table 44. BCG Tuberculosis (TB) Vaccine Market: Company Product Application Footprint
Table 45. BCG Tuberculosis (TB) Vaccine New Market Entrants and Barriers to Market Entry
Table 46. BCG Tuberculosis (TB) Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global BCG Tuberculosis (TB) Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 48. Global BCG Tuberculosis (TB) Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 49. Global BCG Tuberculosis (TB) Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 50. Global BCG Tuberculosis (TB) Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 51. Global BCG Tuberculosis (TB) Vaccine Average Price by Region (2019-2024) & (USD/Unit)
Table 52. Global BCG Tuberculosis (TB) Vaccine Average Price by Region (2025-2030) & (USD/Unit)
Table 53. Global BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 54. Global BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 55. Global BCG Tuberculosis (TB) Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 56. Global BCG Tuberculosis (TB) Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 57. Global BCG Tuberculosis (TB) Vaccine Average Price by Type (2019-2024) & (USD/Unit)
Table 58. Global BCG Tuberculosis (TB) Vaccine Average Price by Type (2025-2030) & (USD/Unit)
Table 59. Global BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 60. Global BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 61. Global BCG Tuberculosis (TB) Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 62. Global BCG Tuberculosis (TB) Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 63. Global BCG Tuberculosis (TB) Vaccine Average Price by Application (2019-2024) & (USD/Unit)
Table 64. Global BCG Tuberculosis (TB) Vaccine Average Price by Application (2025-2030) & (USD/Unit)
Table 65. North America BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 66. North America BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 67. North America BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 68. North America BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 69. North America BCG Tuberculosis (TB) Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 70. North America BCG Tuberculosis (TB) Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 71. North America BCG Tuberculosis (TB) Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 72. North America BCG Tuberculosis (TB) Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 73. Europe BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 74. Europe BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 75. Europe BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 76. Europe BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 77. Europe BCG Tuberculosis (TB) Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 78. Europe BCG Tuberculosis (TB) Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 79. Europe BCG Tuberculosis (TB) Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe BCG Tuberculosis (TB) Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 82. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 83. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 84. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 85. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 86. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 87. Asia-Pacific BCG Tuberculosis (TB) Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 88. Asia-Pacific BCG Tuberculosis (TB) Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 89. South America BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 90. South America BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 91. South America BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 92. South America BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 93. South America BCG Tuberculosis (TB) Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 94. South America BCG Tuberculosis (TB) Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 95. South America BCG Tuberculosis (TB) Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 96. South America BCG Tuberculosis (TB) Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 97. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 98. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 99. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 100. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 101. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 102. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 103. Middle East & Africa BCG Tuberculosis (TB) Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 104. Middle East & Africa BCG Tuberculosis (TB) Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 105. BCG Tuberculosis (TB) Vaccine Raw Material
Table 106. Key Manufacturers of BCG Tuberculosis (TB) Vaccine Raw Materials
Table 107. BCG Tuberculosis (TB) Vaccine Typical Distributors
Table 108. BCG Tuberculosis (TB) Vaccine Typical Customers
LIST OF FIGURES
Figure 1. BCG Tuberculosis (TB) Vaccine Picture
Figure 2. Global BCG Tuberculosis (TB) Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global BCG Tuberculosis (TB) Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Immune BCG Examples
Figure 5. Therapy BCG Examples
Figure 6. Global BCG Tuberculosis (TB) Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global BCG Tuberculosis (TB) Vaccine Consumption Value Market Share by Application in 2023
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global BCG Tuberculosis (TB) Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global BCG Tuberculosis (TB) Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global BCG Tuberculosis (TB) Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 13. Global BCG Tuberculosis (TB) Vaccine Average Price (2019-2030) & (USD/Unit)
Figure 14. Global BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global BCG Tuberculosis (TB) Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of BCG Tuberculosis (TB) Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 BCG Tuberculosis (TB) Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 BCG Tuberculosis (TB) Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global BCG Tuberculosis (TB) Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 21. North America BCG Tuberculosis (TB) Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe BCG Tuberculosis (TB) Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific BCG Tuberculosis (TB) Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. South America BCG Tuberculosis (TB) Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa BCG Tuberculosis (TB) Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Global BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global BCG Tuberculosis (TB) Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 28. Global BCG Tuberculosis (TB) Vaccine Average Price by Type (2019-2030) & (USD/Unit)
Figure 29. Global BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global BCG Tuberculosis (TB) Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 31. Global BCG Tuberculosis (TB) Vaccine Average Price by Application (2019-2030) & (USD/Unit)
Figure 32. North America BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America BCG Tuberculosis (TB) Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 36. United States BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe BCG Tuberculosis (TB) Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific BCG Tuberculosis (TB) Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 52. China BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America BCG Tuberculosis (TB) Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa BCG Tuberculosis (TB) Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. BCG Tuberculosis (TB) Vaccine Market Drivers
Figure 73. BCG Tuberculosis (TB) Vaccine Market Restraints
Figure 74. BCG Tuberculosis (TB) Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of BCG Tuberculosis (TB) Vaccine in 2023
Figure 77. Manufacturing Process Analysis of BCG Tuberculosis (TB) Vaccine
Figure 78. BCG Tuberculosis (TB) Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. BCG Tuberculosis (TB) Vaccine Picture
Figure 2. Global BCG Tuberculosis (TB) Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global BCG Tuberculosis (TB) Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Immune BCG Examples
Figure 5. Therapy BCG Examples
Figure 6. Global BCG Tuberculosis (TB) Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global BCG Tuberculosis (TB) Vaccine Consumption Value Market Share by Application in 2023
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global BCG Tuberculosis (TB) Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global BCG Tuberculosis (TB) Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global BCG Tuberculosis (TB) Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 13. Global BCG Tuberculosis (TB) Vaccine Average Price (2019-2030) & (USD/Unit)
Figure 14. Global BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global BCG Tuberculosis (TB) Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of BCG Tuberculosis (TB) Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 BCG Tuberculosis (TB) Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 BCG Tuberculosis (TB) Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global BCG Tuberculosis (TB) Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 21. North America BCG Tuberculosis (TB) Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe BCG Tuberculosis (TB) Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific BCG Tuberculosis (TB) Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. South America BCG Tuberculosis (TB) Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa BCG Tuberculosis (TB) Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Global BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global BCG Tuberculosis (TB) Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 28. Global BCG Tuberculosis (TB) Vaccine Average Price by Type (2019-2030) & (USD/Unit)
Figure 29. Global BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global BCG Tuberculosis (TB) Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 31. Global BCG Tuberculosis (TB) Vaccine Average Price by Application (2019-2030) & (USD/Unit)
Figure 32. North America BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America BCG Tuberculosis (TB) Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 36. United States BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe BCG Tuberculosis (TB) Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific BCG Tuberculosis (TB) Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 52. China BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America BCG Tuberculosis (TB) Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa BCG Tuberculosis (TB) Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa BCG Tuberculosis (TB) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. BCG Tuberculosis (TB) Vaccine Market Drivers
Figure 73. BCG Tuberculosis (TB) Vaccine Market Restraints
Figure 74. BCG Tuberculosis (TB) Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of BCG Tuberculosis (TB) Vaccine in 2023
Figure 77. Manufacturing Process Analysis of BCG Tuberculosis (TB) Vaccine
Figure 78. BCG Tuberculosis (TB) Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
